Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Radiation Dose Management Market to Gain US$ 1,361.5 Mn in 2026, Says TMR


ALBANY, New York, July 13, 2018 /PRNewswire/ --

Transparency Market Research has published a new report titled, "Radiation Dose Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026". According to the report, the global radiation dose management market was valued at US$ 143.2 Mn in 2017 and is projected to expand at a CAGR of 26.7% from 2018 to 2026 to reach US$ 1,361.5 Mn in 2026. Rise in prevalence of chronic diseases such as cardiovascular and cancer, increase in geriatric population, growing safety concerns and improving quality of patient care, surge in demand for medical imaging, emerging economies in Asia Pacific, Latin America, and Middle East & Africa, and technological advancements are expected to propel the global radiation dose management market during the forecast period.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25394

Increase in Usage of Integrated Software Systems 

Owing to increasing number of chronic diseases such as cardiovascular, cancer and increasing demand for medical imaging in diagnosis of these diseases, compiled with the prime intent of updating the stakeholders with the unavoidable market parameters through a graphical illustration and in-depth analysis of each segment considered within the study scope. Increase in government funding to setup high quality health care infrastructure is anticipated to propel the market during the forecast period. Rise in usage of integrated software in medical imaging devices which enables the interlinking of various images and databases is expected to augment the market. Surge in funding from government and private sector for oncology treatment in terms of reimbursement is likely to contribute to the growth of the market. Increase in government programs to prevent high radiation dose is projected to propel the market during the forecast period.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=25394

Computed Tomography Held Major Market Share 

In terms of modality, the computed tomography segment accounted for major market share in 2017. Growth of the segment is attributed to increase in number of diseases and requirement of CT scan for diagnosis of these diseases. The radiography and mammography segment is likely to be driven by increase in application in the diagnosis and treatment analysis of cancer at various stages and in the diagnosis of orthopedic, dental, and chronic conditions such as pneumonia.

Rise in Cancer Cases across the Globe 

In terms of application, the oncology segment held the major market share in 2017 and the trend is projected to continue during the forecast period. Growth of the segment is attributed to increasing number of cancer cases. Moreover, according to WHO report, cancer is expected to account for 70% of global deaths in the next two decades. Surge in the number of orthopedic cases and usage of different imaging techniques during the course of the treatment are likely to fuel the growth of the segment.

Request a Sample of Radiation Dose Management Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25394

Hospitals Segment Dominates Market 

The hospitals segment accounted for the largest share of the market in 2017. The predominance of the market share of the hospitals segments over other segments is because, hospital pharmacy is mostly preferred by patients owing to the fact that all types of diagnosis is widely available in hospitals as compared to others. Additionally, increasing incidence of chronic diseases such as cancer, cardiovascular diseases are well treated in the hospitals. Initiatives by government bodies to develop health care infrastructure and to attract women are projected to propel the hospitals segment. Ambulatory centers contribute less for the growth radiation dose monitoring market, due to high installment cost of medical devices which is a restraining factor for the clinics to provide this facility

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=25394

Asia Pacific to Witness Exponential Growth 

Asia Pacific is projected to be the fastest growing market for radiation dose management during the forecast period owing to increase in incidence of chronic diseases and rise in awareness about diagnosis, especially in China and Japan. Moreover, surge in investments to enhance the adoption of health care IT technologies in countries such as India and Australia drives demand for radiation dose management solutions. North America held major share of the global radiation dose management market in 2017, attributed to well-established health care infrastructure, presence of key players, and favorable reimbursement policy. Moreover, incidence of cancer, cardiovascular diseases, and neurological disorders is increasing in North America which require imaging tests for diagnosis. Emerging markets such as Latin America and Middle East & Africa are also likely to witness strong growth due to the emergence of key players in these regions and increase in incidence of diseases.

Afga-Gevaert N.V., Bayer Healthcare AG, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific, and Fujifilm Holdings Corporation to Lead the Market

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/



These press releases may also interest you

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...

at 07:05
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its lead program in severe hemophilia A at the World...



News published on and distributed by: